GLOSSARY

This glossary contains definitions of certain terms used in this prospectus in
connection with our business. Some of these terms may not correspond to standard
industry definitions.

“adalimumab”

“AE”

sold under the trade name Humira among others, an
FDA-approved TNF-␣ blocker used to treat rheumatoid
ankylosing spondylitis, Crohn’s
arthritis, psoriasis,
disease, ulcerative
colitis, hidradenitis
suppurativa,
uveitis and juvenile idiopathic arthritis

adverse event, any untoward medical occurrence in a
patient or clinical investigation subject administered a
drug or other pharmaceutical product during clinical
trials, which does not necessarily have
causal
relationship with the treatment

a

“albuminuria”

a pathological condition wherein the protein albumin is
abnormally present in the urine

“ALT”

“amylase”

“anemia”

“ankylosing spondylitis”

“antibody”

“arthritis”

“AST”

alanine aminotransferase, a liver enzyme that is released
in the blood where liver cells are damaged; the blood test
for ALT is used to diagnose liver disorders

an enzyme that catalyzes the hydrolysis of starch into
sugars

a decrease in the total amount of red blood cells (RBCs)
or hemoglobin in the blood, or a lowered ability of the
blood to carry oxygen

a form of arthritis that primarily affects the spine, causing
inflammation of the spinal joints that can lead to severe,
chronic pain and discomfort

protein produced by B cells in response to a foreign
molecule or
invading microorganism. Also called
immunoglobulin

inflammation of the joints in one or more areas of the
body

aspartate transaminase or aspartate aminotransferase; the
blood test for AST is usually used to detect liver damage

– 34 –

